TAK

Takeda Pharma
NYSE

Real-time Quotes | Nasdaq Last Sale

18.49
-0.06
-0.32%
After Hours: 18.49 0 0.00% 17:30 08/14 EDT
OPEN
18.53
PREV CLOSE
18.55
HIGH
18.57
LOW
18.46
VOLUME
498.00K
TURNOVER
--
52 WEEK HIGH
20.93
52 WEEK LOW
12.43
MARKET CAP
57.80B
P/E (TTM)
58.85
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average TAK stock price target is 23.42 with a high estimate of 26.00 and a low estimate of 20.84.

EPS

TAK News

More
Glenview Capital picks up DaVita & Lyft; reduces ViacomCBS & Takeda
Glenview Capital (Larry Robbins and Mark Horowitz) reports fund value of $3.63B at the end of Q2.Picked up new stakes in DaVita (DVA) 0.79M shares, Host Hotels & Resorts (HST)
Seekingalpha · 55m ago
National Hemophilia Foundation and Takeda Partner with Alex Borstein to Raise Awareness of von Willebrand Disease
A new series of public service announcements featuring actress Alex Borstein aims to educate the public about the symptoms of von Willebrand disease.
Business Wire · 4d ago
Novavax Inks Vaccine Deals In Japan, India; Analyst Sees 70% Stock Upside
SmarterAnalyst · 5d ago
Novavax Partners With Takeda for Japan Output of Covid Drug
Takeda will leverage its manufacturing capabilities in Japan to produce Novavax's coronavirus treatment candidate.
TheStreet.com · 08/07 19:00
Coronavirus update: NY's Cuomo OKs sending students back to school as vaccine optimism rises
New York’s school districts will welcome students back into classrooms in the fall, Governor Andrew Cuomo announced on Friday, as the former coronavirus epicenter continues on its recovery.
Yahoo Finance · 08/07 16:27
Novavax Announces Deals to Sell Covid-19 Vaccine in India, Japan, and Low-Income Countries
The biotech company (NVAX)has announced agreements to join with other drugmakers to market its drugs in Japan, India, and low- and middle-income countries around the world. The news came days after Novavax (ticker: NVAX) released data on its Covid-19 vaccine
Barrons.com · 08/07 15:58
Novavax inks deal with Takeda for COVID-19 vaccine in Japan
Takeda Pharmaceutical Company (NYSE:TAK) enters into an agreement with Novavax (NASDAQ:NVAX) to develop, manufacture and commercialize the latter's COVID-1
seekingalpha · 08/07 15:39
The Daily Biotech Pulse: Novavax Vaccine Deals, Trevena Awaits FDA Decision, 2 IPOs
Benzinga · 08/07 12:34

Industry

Pharmaceuticals
-0.32%
Pharmaceuticals & Medical Research
-0.38%

Hot Stocks

Symbol
Price
%Change

About TAK

Takeda Pharmaceutical Company Limited is a Japan-based company mainly engaged in the pharmaceutical business. The Company is engaged in the research, development, manufacture and sale of pharmaceutical products, General medical products, quasi drugs and healthcare products in Japan and overseas. The Company's research and development functions are concentrated in four areas of oncology (cancer), digestive system diseases, rare diseases and neurology (neuropsychiatric diseases), as well as two business units of plasma fractionation products and vaccines. The Company is engaged in the improvement of pipelines at research and development centers located mainly in Japan and the United States.
More

Webull offers kinds of Takeda Pharmaceutical Co Ltd (ADR) stock information, including NYSE:TAK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TAK stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading TAK stock methods without spending real money on the virtual paper trading platform.